Preclinical Feasibility Study of NMP179, a Nuclear Matrix Protein Marker for Cervical Dysplasia

Publisher： Karger

E-ISSN： 1938-2650|43|6|1015-1022

ISSN： 0001-5547

Source： Acta Cytologica, Vol.43, Iss.6, 2011-08, pp. : 1015-1022

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A Multi-Institutional Feasibility Study on the Use of Automated Screening Systems for Quality Control Rescreening of Cervical Cytology

By  

Acta Cytologica, Vol. 60, Iss. 5, 2016-09 ,pp. : 451-457

Karger

Access to resources Recommend Favorite

Correlation of HPV16 L1 Capsid Protein Expression in Cervical Dysplasia with HPV16 DNA Concentration, HPV16 E6*I mRNA and Histologic Outcome

By  

Acta Cytologica, Vol. 53, Iss. 4, 2011-02 ,pp. : 396-401

Karger

Access to resources Recommend Favorite

Prognostic Features of Cervical Dysplasia Associated with Specific Types of HPV DNA and Cytologic Features Characteristic of HPV Infection in Dysplasia

By  

Acta Cytologica, Vol. 42, Iss. 6, 2011-08 ,pp. : 1377-1381

Karger

Access to resources Recommend Favorite

Feasibility of Cytology-Based Cervical Cancer Screening in Rural Cameroon

By  

Acta Cytologica, Vol. 46, Iss. 6, 2011-03 ,pp. : 1110-1116

Karger

Access to resources Recommend Favorite

Nuclear Grooves in Normal and Abnormal Cervical Smears

By  

Acta Cytologica, Vol. 47, Iss. 3, 2011-02 ,pp. : 421-425

Karger

Access to resources Recommend Favorite